02/07/2001 (Agence Europe) - At the Annual General Meeting of EFPIA (the European Pharmaceutical Industry Federation) in Lucerne on 19-22 July, the EFPIA President Jean-François Dehecq (Sanofi-Synthélabo) again insisted that the European Union was losing its attraction to the pharmaceutical industry, noting that the biggest innovative laboratories only spent 59% of their Research and Development credits in the EU in 1999, compared with 73% in 1990. Pointing out that the United States had...